Heme oxygenase-1: an emerging therapeutic target to curb cardiac pathology

[1]  G. Czibik,et al.  Citric Acid Cycle Intermediates in Cardioprotection , 2014, Circulation. Cardiovascular genetics.

[2]  P. Dennery,et al.  Nuclear Heme Oxygenase-1 (HO-1) Modulates Subcellular Distribution and Activation of Nrf2, Impacting Metabolic and Anti-oxidant Defenses* , 2014, The Journal of Biological Chemistry.

[3]  M. Simionescu,et al.  Remote Transplantation of Mesenchymal Stem Cells Protects the Heart Against Ischemia‐Reperfusion Injury , 2014, Stem cells.

[4]  R. Chibbar,et al.  Heme oxygenase suppresses markers of heart failure and ameliorates cardiomyopathy in L-NAME-induced hypertension. , 2014, European journal of pharmacology.

[5]  O. Wagner,et al.  Heme Oxygenase-1 Drives Metaflammation and Insulin Resistance in Mouse and Man , 2014, Cell.

[6]  K. Brunt,et al.  Heme oxygenase-1 overexpression exacerbates heart failure with aging and pressure overload but is protective against isoproterenol-induced cardiomyopathy in mice. , 2014, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[7]  Peter Libby,et al.  Cardiovascular remodelling in coronary artery disease and heart failure , 2014, The Lancet.

[8]  M. Laakso,et al.  Insulin resistance and hyperglycaemia in cardiovascular disease development , 2014, Nature Reviews Endocrinology.

[9]  S. Lipshultz,et al.  Anthracycline-Induced Cardiotoxicity: A Review of Pathophysiology, Diagnosis, and Treatment , 2014, Current Treatment Options in Cardiovascular Medicine.

[10]  Sanjiv J. Shah,et al.  Developing therapies for heart failure with preserved ejection fraction: current state and future directions. , 2014, JACC. Heart failure.

[11]  G. Lopaschuk,et al.  Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy , 2014, British journal of pharmacology.

[12]  R. Kornowski,et al.  Heme Oxygenase-1 Induction Improves Cardiac Function following Myocardial Ischemia by Reducing Oxidative Stress , 2014, PloS one.

[13]  S. Moebus,et al.  Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study , 2014, Clinical Research in Cardiology.

[14]  R. Foresti,et al.  Heme oxygenase-1 as a target for drug discovery. , 2014, Antioxidants & redox signaling.

[15]  S. Wehrli,et al.  Expression Level and Subcellular Localization of Heme Oxygenase-1 Modulates Its Cytoprotective Properties in Response to Lung Injury: A Mouse Model , 2014, PloS one.

[16]  Jessica L. Cohen,et al.  Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. , 2014, Cell metabolism.

[17]  J. Dubois-Randé,et al.  Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. , 2013, Pharmacological research.

[18]  W. Wang,et al.  Heme Oxygenase-1 Prevents Cardiac Dysfunction in Streptozotocin-Diabetic Mice by Reducing Inflammation, Oxidative Stress, Apoptosis and Enhancing Autophagy , 2013, PloS one.

[19]  S. Barnes,et al.  Mitochondria-targeted heme oxygenase-1 decreases oxidative stress in renal epithelial cells. , 2013, American journal of physiology. Renal physiology.

[20]  S. Bansal,et al.  Mitochondria-targeted heme oxygenase-1 induces oxidative stress and mitochondrial dysfunction in macrophages, kidney fibroblasts and in chronic alcohol hepatotoxicity , 2013, Redox biology.

[21]  M. Irwin,et al.  N-Acetylcysteine and Allopurinol Confer Synergy in Attenuating Myocardial Ischemia Injury via Restoring HIF-1α/HO-1 Signaling in Diabetic Rats , 2013, PloS one.

[22]  Kwok-Kin Wong,et al.  Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. , 2013, The Journal of clinical investigation.

[23]  P. Libby,et al.  Immune effector mechanisms implicated in atherosclerosis: from mice to humans. , 2013, Immunity.

[24]  D. Stec,et al.  Chronic Carbon Monoxide Treatment Attenuates Development of Obesity and Remodels Adipocytes in Mice Fed a High Fat Diet , 2013, International Journal of Obesity.

[25]  Jessica L. Cohen,et al.  Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice , 2013, Proceedings of the National Academy of Sciences.

[26]  L. V. Van Laake,et al.  Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. , 2013, Cardiovascular research.

[27]  L. Cai,et al.  Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation. , 2013, Journal of molecular and cellular cardiology.

[28]  G. Heusch.  Cardioprotection: chances and challenges of its translation to the clinic , 2013, The Lancet.

[29]  I. Petersen,et al.  Cardiovascular Events as a Function of Serum Bilirubin Levels in a Large, Statin-Treated Cohort , 2012, Circulation.

[30]  G. Valen,et al.  Protecting the heart through delivering DNA encoding for heme oxygenase-1 into skeletal muscle. , 2012, Life sciences.

[31]  E. Abel,et al.  Mechanisms of Lipotoxicity in the Cardiovascular System , 2012, Current Hypertension Reports.

[32]  D. Arnold,et al.  Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. , 2012, The New England journal of medicine.

[33]  J. S. Janicki,et al.  Triterpenoid Dihydro-CDDO-Trifluoroethyl Amide Protects against Maladaptive Cardiac Remodeling and Dysfunction in Mice: A Critical Role of Nrf2 , 2012, PloS one.

[34]  S. Lancel,et al.  Carbon Monoxide Improves Cardiac Function and Mitochondrial Population Quality in a Mouse Model of Metabolic Syndrome , 2012, PloS one.

[35]  H. Aburatani,et al.  Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. , 2012, Cancer cell.

[36]  H. Drummond,et al.  Expression of heme oxygenase-1 in thick ascending loop of henle attenuates angiotensin II-dependent hypertension. , 2012, Journal of the American Society of Nephrology : JASN.

[37]  Alan J. Robinson,et al.  Fumarate Is Cardioprotective via Activation of the Nrf2 Antioxidant Pathway , 2012, Cell metabolism.

[38]  杜昕,et al.  Inherited cardiomyopathies , 2012 .

[39]  J. Olefsky,et al.  Increased Macrophage Migration Into Adipose Tissue in Obese Mice , 2012, Diabetes.

[40]  Tom R. Gaunt,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[41]  S. yet,et al.  A central role of heme oxygenase-1 in cardiovascular protection. , 2011, Antioxidants & redox signaling.

[42]  O. Nakajima,et al.  Systemic Heme Oxygenase-1 Transgenic Overexpression Aggravates Pressure Overload-induced Cardiac Hypertrophy in Mice , 2011, Cellular Physiology and Biochemistry.

[43]  V. Procaccio,et al.  Heme Oxygenase 1 Is Differentially Involved in Blood Flow–Dependent Arterial Remodeling: Role of Inflammation, Oxidative Stress, and Nitric Oxide , 2011, Hypertension.

[44]  N. Chen,et al.  Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences , 2011, Basic Research in Cardiology.

[45]  V. Eder,et al.  Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling. , 2011, Cardiovascular research.

[46]  Scott E. Kern,et al.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.

[47]  Kevin Pearson,et al.  Adaptive induction of NF‐E2–Related Factor‐2‐driven antioxidant genes in endothelial cells in response to hyperglycemia , 2011, American journal of physiology. Heart and circulatory physiology.

[48]  D. Stec,et al.  Chronic HO-1 Induction with Cobalt Protoporphyrin (CoPP) Treatment Increases Oxygen Consumption, Activity, Heat Production and Lowers Body Weight in Obese Melanocortin-4 Receptor Deficient Mice , 2011, International Journal of Obesity.

[49]  Christopher J. Davidson,et al.  Sustained activation of nuclear erythroid 2-related factor 2/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation cardiomyopathy in mice. , 2011, Antioxidants & redox signaling.

[50]  G. Czibik,et al.  Gene therapy with hypoxia-inducible factor 1 alpha in skeletal muscle is cardioprotective in vivo. , 2011, Life sciences.

[51]  W. Brück,et al.  Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. , 2011, Brain : a journal of neurology.

[52]  L. Rodella,et al.  Adipocyte Heme Oxygenase-1 Induction Attenuates Metabolic Syndrome in Both Male and Female Obese Mice , 2010, Hypertension.

[53]  W. Durante.  Targeting heme oxygenase-1 in vascular disease. , 2010, Current drug targets.

[54]  X. Ren,et al.  Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium , 2010, Journal of Biomedical Science.

[55]  L. Otterbein,et al.  The therapeutic potential of carbon monoxide , 2010, Nature Reviews Drug Discovery.

[56]  F. Hu,et al.  Plasma Heme Oxygenase-1 Concentration Is Elevated in Individuals with Type 2 Diabetes Mellitus , 2010, PloS one.

[57]  X. Ren,et al.  HO-1 modified mesenchymal stem cells modulate MMPs/TIMPs system and adverse remodeling in infarcted myocardium. , 2010, Tissue & cell.

[58]  R. de Cabo,et al.  Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2 , 2010, American journal of physiology. Heart and circulatory physiology.

[59]  G. Czibik.  Complex role of the HIF system in cardiovascular biology , 2010, Journal of Molecular Medicine.

[60]  Hanna Forstén,et al.  Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B. , 2010, European journal of pharmacology.

[61]  R. Bolli,et al.  Cardioprotective and Antiapoptotic Effects of Heme Oxygenase-1 in the Failing Heart , 2010, Circulation.

[62]  Masahiko Zuka,et al.  Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia. , 2010, American journal of physiology. Heart and circulatory physiology.

[63]  G. Smyth,et al.  Pro-Inflammatory CD11c+CD206+ Adipose Tissue Macrophages Are Associated With Insulin Resistance in Human Obesity , 2010, Diabetes.

[64]  J. Boyle,et al.  PPARdelta and PGC1alpha act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress. , 2010, Cardiovascular research.

[65]  J. S. Janicki,et al.  Dihydro-CDDO-Trifluoroethyl Amide (dh404), a Novel Nrf2 Activator, Suppresses Oxidative Stress in Cardiomyocytes , 2009, PloS one.

[66]  J. S. Janicki,et al.  Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[67]  D. Gu,et al.  Association of an Intronic Variant of the Heme Oxygenase-1 Gene with Hypertension in Northern Chinese Han Population , 2009, Clinical and experimental hypertension.

[68]  G. Heusch,et al.  Loss of cardioprotection with ageing. , 2009, Cardiovascular research.

[69]  K. Brunt,et al.  Heme Oxygenase-1 Inhibits Pro-Oxidant Induced Hypertrophy in HL-1 Cardiomyocytes , 2009, Experimental biology and medicine.

[70]  K. Chang,et al.  Hemin inhibits hypertensive rat vascular smooth muscle cell proliferation through regulation of cyclin D and p21 , 2009, Archives of pharmacal research.

[71]  H. Carlsen,et al.  Cardioprotection by hypoxia-inducible factor 1 alpha transfection in skeletal muscle is dependent on haem oxygenase activity in mice. , 2009, Cardiovascular research.

[72]  Ø. Skare,et al.  In vivo Remote Delivery of DNA Encoding for Hypoxia‐inducible Factor 1 Alpha Reduces Myocardial Infarct Size , 2009, Clinical and translational science.

[73]  M. Carraway,et al.  Heme Oxygenase-1 Regulates Cardiac Mitochondrial Biogenesis via Nrf2-Mediated Transcriptional Control of Nuclear Respiratory Factor-1 , 2008, Circulation research.

[74]  G. Czibik,et al.  Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia-inducible factor 1 alpha in the heart. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[75]  D. Stec,et al.  Kidney-Specific Induction of Heme Oxygenase-1 Prevents Angiotensin II Hypertension , 2008, Hypertension.

[76]  X. Ren,et al.  Paracrine action of HO‐1‐modified mesenchymal stem cells mediates cardiac protection and functional improvement , 2008, Cell biology international.

[77]  Shing‐Jong Lin,et al.  Serum Bilirubin and Ferritin Levels Link Heme Oxygenase-1 Gene Promoter Polymorphism and Susceptibility to Coronary Artery Disease in Diabetic Patients , 2008, Diabetes Care.

[78]  S. yet,et al.  Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. , 2008, Journal of molecular and cellular cardiology.

[79]  Shinji Mito,et al.  Myocardial Protection Against Pressure Overload in Mice Lacking Bach1, a Transcriptional Repressor of Heme Oxygenase-1 , 2008, Hypertension.

[80]  N. Abraham,et al.  Pharmacological and Clinical Aspects of Heme Oxygenase , 2008, Pharmacological Reviews.

[81]  A. Agarwal,et al.  Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. , 2008, Circulation.

[82]  M. Carraway,et al.  The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. , 2007, The Journal of clinical investigation.

[83]  D. Yellon,et al.  Myocardial reperfusion injury. , 2007, The New England journal of medicine.

[84]  S. Odelberg,et al.  Human αB-Crystallin Mutation Causes Oxido-Reductive Stress and Protein Aggregation Cardiomyopathy in Mice , 2007, Cell.

[85]  K. Brunt,et al.  Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction. , 2007, American journal of physiology. Heart and circulatory physiology.

[86]  L. Chau,et al.  Systemic Expression of Heme Oxygenase-1 Ameliorates Type 1 Diabetes in NOD Mice , 2007, Diabetes.

[87]  Stefan Neubauer,et al.  The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.

[88]  N. Abraham,et al.  Long-Lasting Expression of HO-1 Delays Progression of Type I Diabetes in NOD Mice , 2007, Cell cycle.

[89]  D. Kass,et al.  Role of oxidative stress in cardiac hypertrophy and remodeling. , 2007, Hypertension.

[90]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[91]  Morris J. Brown,et al.  Heme oxygenase‐1 gene transfer inhibits angiotensin II‐mediated rat cardiac myocyte apoptosis but not hypertrophy , 2006, Journal of cellular physiology.

[92]  Ajay M Shah,et al.  Oxidative stress and redox signalling in cardiac hypertrophy and heart failure , 2006, Heart.

[93]  M. Gnecchi,et al.  Heme oxygenase‐1 (HO‐1) inhibits postmyocardial infarct remodeling and restores ventricular function , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[94]  Y. Tang,et al.  Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. , 2005, Journal of the American College of Cardiology.

[95]  A. Agarwal,et al.  A hypoxia-inducible vigilant vector system for activating therapeutic genes in ischemia , 2005, Gene Therapy.

[96]  A. Fowler,et al.  HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. , 2005, American journal of physiology. Heart and circulatory physiology.

[97]  M. Layne,et al.  Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. , 2005, Diabetes.

[98]  RyozoNagai,et al.  Carbon Monoxide Protects Against Cardiac Ischemia—Reperfusion Injury In Vivo via MAPK and Akt—eNOS Pathways , 2004 .

[99]  S. Solomon,et al.  Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[100]  H. Drexler,et al.  Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes. , 2004, Cardiovascular research.

[101]  L. Chau,et al.  Heme Oxygenase-1 Inhibits Angiotensin II–Induced Cardiac Hypertrophy In Vitro and In Vivo , 2004, Circulation.

[102]  E. Ogier-Denis,et al.  Induction of Heme Oxygenase-1 Inhibits NAD(P)H Oxidase Activity by Down-regulating Cytochrome b558 Expression via the Reduction of Heme Availability* , 2004, Journal of Biological Chemistry.

[103]  G. Stassi,et al.  Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[104]  R. Bolli,et al.  Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. , 2004, American journal of physiology. Heart and circulatory physiology.

[105]  Y. Tang,et al.  Protection From Ischemic Heart Injury by a Vigilant Heme Oxygenase-1 Plasmid System , 2004, Hypertension.

[106]  P. Kovacs,et al.  Heme oxygenase‐1 related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[107]  P. Naughton,et al.  Cardioprotective Actions by a Water‐Soluble Carbon nMonoxide‐Releasing Molecule , 2003, Circulation research.

[108]  RyozoNagai,et al.  Heme Oxygenase-1 Gene Promoter Polymorphism Is Associated With Coronary Artery Disease in Japanese Patients With Coronary Risk Factors , 2002 .

[109]  C. Liang,et al.  Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. , 2002, American journal of physiology. Heart and circulatory physiology.

[110]  W. Pan,et al.  Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients , 2002, Human Genetics.

[111]  J. Oyama,et al.  Gene Therapy Strategy for Long-Term Myocardial Protection Using Adeno-Associated Virus-Mediated Delivery of Heme Oxygenase Gene , 2002, Circulation.

[112]  A. Shah,et al.  Pivotal Role of a gp91phox-Containing NADPH Oxidase in Angiotensin II-Induced Cardiac Hypertrophy in Mice , 2002, Circulation.

[113]  R. Foresti,et al.  Role of heme oxygenase-1 in hypoxia-reoxygenation: requirement of substrate heme to promote cardioprotection. , 2001, American journal of physiology. Heart and circulatory physiology.

[114]  J. Ingwall,et al.  Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice , 2001, Circulation research.

[115]  James L. Park,et al.  Heme oxygenase-1 protects against vascular constriction and proliferation , 2001, Nature Medicine.

[116]  H. Rennke,et al.  Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1–Deficient Mice , 2001, Circulation research.

[117]  J. Alam,et al.  Hmox-1 Constitutes an Adaptive Response to Effect Antioxidant Cardioprotection: A Study With Transgenic Mice Heterozygous for Targeted Disruption of the Heme Oxygenase-1 Gene , 2001, Circulation.

[118]  M. Onji,et al.  In Situ Characterization of Dendritic Cells Occurring in the Islets of Nonobese Diabetic Mice During the Development of Insulitis , 2000, Pancreas.

[119]  P. Sarathchandra,et al.  Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. , 2000, American journal of physiology. Heart and circulatory physiology.

[120]  J Zaky,et al.  Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. , 1999, The Journal of clinical investigation.

[121]  A. Choi,et al.  Nrf2, a Cap’n’Collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene* , 1999, The Journal of Biological Chemistry.

[122]  R. Winslow,et al.  Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. , 1998, Circulation research.

[123]  H. Maegawa,et al.  Altered Activities of Transcription Factors and Their Related Gene Expression in Cardiac Tissues of Diabetic Rats , 1998, Diabetes.

[124]  G. Semenza,et al.  Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia* , 1997, The Journal of Biological Chemistry.

[125]  R. A. Johnson,et al.  Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. , 1996, The American journal of physiology.

[126]  A. Choi,et al.  Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation. , 1995, American journal of respiratory cell and molecular biology.

[127]  N. Abraham,et al.  Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[128]  S. Snyder,et al.  Carbon monoxide: a putative neural messenger. , 1993, Science.

[129]  S. Shibahara,et al.  Human heme oxygenase cDNA and induction of its mRNA by hemin. , 1988, European journal of biochemistry.

[130]  D. Godin,et al.  Alterations in Free Radical Tissue-Defense Mechanisms in Streptozocin-Induced Diabetes in Rat: Effects of Insulin Treatment , 1987, Diabetes.

[131]  B. Ames,et al.  Bilirubin is an antioxidant of possible physiological importance. , 1987, Science.

[132]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[133]  M. Maines,et al.  Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. , 1986, The Journal of biological chemistry.

[134]  B. Matkovics,et al.  The Effect of Diabetes on the Activities of the Peroxide Metabolism Enzymes , 1982, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[135]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[136]  P. Cooper.  What will reorganisation do for the patient , 1974 .

[137]  L. Opie,et al.  Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. , 1968, Lancet.

[138]  GenevièveDerumeaux,et al.  p21-Dependent Protective Effects of a Carbon Monoxide–Releasing Molecule-3 in Pulmonary Hypertension , 2014 .

[139]  R. Bolli,et al.  Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium. , 2012, Journal of molecular and cellular cardiology.

[140]  G. Fonarow,et al.  Epidemiology and risk profile of heart failure , 2011, Nature Reviews Cardiology.

[141]  H. Watkins,et al.  Inherited cardiomyopathies. , 2011, The New England journal of medicine.

[142]  G. Smyth,et al.  Adipose tissue macrophages in human obesity Pro-inflammatory CD 11 c + CD 206 + adipose tissue macrophages are associated with insulin resistance in human obesity , 2010 .

[143]  三戸 森児.  Myocardial protection against pressure overload in mice lacking Bach1, a transcriptional repressor of heme oxygenase-1 , 2008 .

[144]  R. Bolli,et al.  Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. , 2005, Journal of molecular and cellular cardiology.

[145]  G. Li Volti.  Letter regarding article by Hu et al, "heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo". , 2005, Circulation.

[146]  Ming-Wei Lin,et al.  Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. , 2004, European heart journal.